Template:Rifabutin: Difference between revisions

Latest revision as of 03:05, 4 January 2014

Rifabutin
MYCOBUTIN^® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

@@ Line 1: / Line 1: @@
 {| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0";
-| style="padding: 0 5px; font-size: 100%; background:#696969" align=center | <span style="color:WHITE;"> '''[[Rifabutin|Rifabutin]]'''</span>
+! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Rifabutin|{{fontcolor|#6C7B8B|Rifabutin}}]]'''''
 |-
-! style="padding: 0 5px; font-size: 85%; background:WHITE" align=left | FDA Package Insert (Rifabutin<sup>®</sup>)
+! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | MYCOBUTIN<sup>®</sup> FDA Package Insert
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Rifabutin description|Description]]
@@ Line 19: / Line 19: @@
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Rifabutin overdosage|Overdosage]]
-|-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Rifabutin clinical studies|Clinical Studies]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Rifabutin dosage and administration|Dosage and Administration]]
-|-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Rifabutin compatibility reconstitution and stability|Compatibility, Reconstitution, and Stability]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Rifabutin how supplied|How Supplied]]